Skip to main content
Exosens logo

Exosens — Investor Relations & Filings

Ticker · EXENS ISIN · FR001400Q9V2 LEI · 969500R3AKTPEDO9EG76 PA Manufacturing
Open in API
Filings indexed 103 across all filing types
Latest filing 2026-05-29 Declaration of Voting R…
Country FR France
Listing PA EXENS

About Exosens

http://www.exosens.com

Exosens is a high-tech company specializing in the innovation, development, and manufacture of high-end electro-optical technologies for amplification, detection, and imaging. The company provides mission-critical components and solutions for demanding environments. Its product portfolio covers a wide optical spectrum from ultraviolet (UV) to longwave infrared (LWIR) and includes image intensifier tubes, advanced digital and infrared cameras, and hyperspectral imaging systems. Exosens also produces a comprehensive range of detectors for electrons, ions, photons, X-rays, neutrons, and gamma radiation, as well as nuclear instrumentation and microwave amplifiers. These technologies serve key markets such as defense and surveillance, life sciences, industrial control, and nuclear safety.

Recent filings

Filing Released Lang Actions
Exosens’ Combined General Meeting of 22 May 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a press release summarizing the Combined General Meeting of Exosens held on 22 May 2026, detailing the approval of financial statements, dividend payment, and director renewals and explicitly noting voting outcomes. This fits the description of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-05-29 English
Assemblée générale mixte d’Exosens du 22 mai 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release summarizing the results of Exosens’ combined ordinary and extraordinary general meeting held on May 22, 2026. It reports quorum figures, which resolutions passed (and which did not), approval of the 2025 accounts, dividend amount, and board renewals. This is precisely a declaration of voting results. Thus it falls under Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-05-29 French
Exosens double sa capacité de production de caméras infrarouges refroidies pour répondre à l’accélération de la demande pour les systèmes de lutte anti-drones à longue portée
Regulatory Filings Classification · 65% confidence The document is a corporate press release announcing Exosens will double its production capacity of cooled infrared cameras in 2026. It does not present financial statements, voting results, dividends, regulatory filings, or officer certifications. It is not an earnings release or an investor presentation. It is a general business update and does not fit any more specific category, so by the fallback rule it should be classified as a Regulatory Filing (RNS).
2026-05-20 French
Exosens doubles production capacity for cooled infrared cameras to meet accelerating demand in long-range counter-drone systems
Regulatory Filings Classification · 40% confidence The document is a corporate press release announcing an operational update (doubling production capacity for cooled infrared cameras) rather than a financial report (e.g., earnings, interim, annual) or specific capital/financing action, board change, dividend notice, M&A, or other predefined category. It does not contain substantive financial statements, forecasts, or attached reports, nor is it a certification or call transcript. As such, it falls under the fallback category for miscellaneous regulatory announcements.
2026-05-20 English
Exosens unifie l’ensemble de ses produits sous une marque unique
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing the unification of product brands under the Exosens name. It contains no financial statements, shareholder vote results, management changes, dividend details, or other defined report content. It is not a financial report or meeting material but a general corporate announcement. Therefore, it falls into the catch-all Regulatory Filings category (RNS).
2026-05-13 French
Exosens unifies all its products under one brand
Regulatory Filings Classification · 24% confidence The document is a corporate press release announcing the unification of product brands under one name. It is not a financial report, earnings release, management or board change, proxy statement, dividend notice, or other specific filing type. It does not present actual financials, legal proceedings, or regulatory attestations, nor does it announce publication of a report. As such, it falls into the fallback category for miscellaneous corporate announcements: Regulatory Filings (RNS).
2026-05-13 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.